Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |